DELCATH
Updated 64 days ago
- Age: 18 years
- ID: 6158606/136
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company's proprietary percutaneous hepatic perfusion (PHP) system is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Also known as: Delcath Systems, Delcath Systems, Inc.
Associated domains: delcathsystems.com